ASİT VE KARSİNOMATOZİS BULGUSU OLMAYAN YÜKSEK OLASILIKLA MALİGN ADNEKSİYEL KİTLELERİN KLİNİK VE PATOLOJİK ÖZELLİKLERİ

Amaç: Amacımız muhtemelen malign adneksiyel kitlesi olan hastaları değerlendirmektir. Gereç ve Yöntem: 2010-2018 yılları arasında salt adneksiyal kitlesi olan ve malignite riski nedeniyle ameliyat yapılan 208 hastanın medikal verileri incelendi. Radyolojik olarak asit ve tümöral implant bulgusu olan hastalar çalışma dışı bırakıldı. Bulgular: Nihai patoloji raporlarına göre 208 hastanın 52'si (%25) benign, 46'sı (%22) borderline ve 110'u (%53) malign idi. En beklenmedik benign tümör seröz kistadenofibrom idi. Malign tümörlerin 3'ü uterin sarkom, 8'i metastatik over kanseri (tümü gastrointestinal kaynaklı), 99'u primer over kanseri idi. Doksan dokuz primer over kanserinin 76'sı epitelyal, 23'ü nonepitelyal idi. En sık görülen histolojik tipler sırasıyla, seröz ve endometrioid adenokarsinom idi. Primer over kanserlerinin %76'sı erken evrede (evre 1-2), %24'ü ileri evrede (evre 3-4) idi. Sonuç: Şüpheli adneksiyal kitlesi olan hastalarda, asit veya karsinomatosiz bulgusu olmasa bile, yüksek malignite riski mevcuttur ve bu risk göz önünde bulundurularak yönetilmelidir.

CLINICOPATHOLOGIC FEATURES OF PROBABLY MALIGNANT ADNEXAL MASSES WITHOUT SIGNS OF ASCITES AND CARCINOMATOSIS

Objective: Our objective was to assess the patients who have probable early stage ovarian cancer. Materal and Method: Between 2010-2018, 208 patients with isolated adnexal masses who underwent surgery due to presumed malignancy were analyzed. We excluded patients with radiologic evidence of ascites and tumour implants. Results: According to the final pathology reports, 52 (25%) of 208 patients had benign tumours, 46 (22%) were borderline, and 110 (53%) patients’ tumours were malignant. The most unexpected benign tumours were serous cystadenofibroma. Of the malignant tumours, 3 were uterine sarcomas, 8 were metastatic ovarian tumours (all gastrointestinal origin), and 99 were primary ovarian cancers. Seventy-six of 99 primary ovarian cancers were epithelial and 23 were nonepithelial. The most common histologic types were respectively serous and endometrioid adenocarcinoma. Seventy-six percent of primary ovarian cancers were early stage (stage 1-2) and 24% were advanced stage (stage 3-4). Conclusion: Patients with a suspicious adnexal mass, even if ascites or carcinomatosis are not existing, have a high rate of malignancy and should be managed considering this risk.

Kaynakça

1. Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2015, National Cancer Institute.

2. Van Calster B, Van Hoorde K, Valentin L, Testa AC, Fischerova D, Van Holsbeke C, Savelli L, Franchi D, Epstein E, Kaijser J, Van Belle V, Czekierdowski A, Guerriero S, Fruscio R, Lanzani C, Scala F, Bourne T, Timmerman D, International Ovarian Tumour Analysis Group Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study. BMJ. 2014;349:g5920. [CrossRef]

3. Bristow RE, Berek JS. Surgery for ovarian cancer: how to improve survival. Lancet 2006;367:1558–60. [CrossRef]

4. Greving JP, Vernooij F, Heintz APM, van der Graaf Y, Buskens E. Is centralization of ovarian cancer care warranted? A cost‐effectiveness analysis Gynecol Oncol 2009;113:68–74. [CrossRef]

5. Vergote I, De Brabanter J, Fyles A, Bertelsen K, Einhorn N, Sevelda P, et al. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 2001;357:176–82. [CrossRef]

6. Demir RH, Marchand GJ. Adnexal Masses Suspected to Be Benign Treated with Laparoscopy. JSLS. 2012;16(1):71–84. [CrossRef]

7. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins— Gynecology. Gynecologists’ Committee on Practice, Practice Bulletin No. 174: evaluation and management of adnexal masses. Obstet Gynecol 2016;128:e210–26. [CrossRef]

8. National Institutes of Health Consensus Development Conference Statement. Ovarian cancer: screening, treatment, and follow-up. Gynecol Oncol 1994; 55:S4. [CrossRef]

9. McDonald JM, Doran S, DeSimone CP, Ueland FR, DePriest PD, Ware RA, Saunders BA, Pavlik EJ, Goodrich S, Kryscio RJ, van Nagell JR Jr. Predicting risk of malignancy in adnexal masses. Obstet Gynecol. 2010 Apr;115(4):687-94. [CrossRef]

10. Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the fallopian tube. Int J Gynaecol Obstet 2006; 95:S145 [CrossRef]

11. Dodge JE, Covens AL, Lacchetti C, et al. Management of a suspicious adnexal mass: a clinical practice guideline. Curr Oncol 2012;19:E244–57. [CrossRef]

12. Engelen MJ, Kos HE, Willemse PH, Aalders JG, de Vries EG, Schaapveld M, et al. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Cancer 2006;106:589-98. [CrossRef]

13. U.S. Food and Drug Administration. OVA1 Next Generation. 510(k) substantial equivalence determination decision summary. Silver Spring (MD): FDA; 2016. Available at: http://www.accessdata.fda.gov/cdrh_ docs/reviews/ K150588.pdf. Retrieved June 24, 2016.

14. U.S. Food and Drug Administration. ROMATM (HE4 EIA + Architect CA125 10TM). 510(k) summary. Silver Spring (MD): FDA; 2011. Available at: http:// www.accessdata.fda.gov/ cdrh_docs/pdf10/K103358.pdf. Retrieved June 24, 2016

15. Royal College of Obstetricians and Gynaecologists (RCOG) Green-top Guideline No. 34. The Management of Ovarian Cysts in Postmenopausal Women. July 2016

16. Kaijser J, Sayasneh A, Van Hoorde K, Ghaem-Maghami S, Bourne T, Timmerman D, et al. Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis. Hum Reprod Update 2014;20:449–62. [CrossRef]

17. Malla VG, Tuteja A, Singh P. Rethinking the Role of Serum Cancer Antigen 125 and Risk of Malignancy Index in Indian Women with Ovarian Masses: Newer Perspectives and Review of Literature. Journal of SAFOG 2018;10(2):110-117. [CrossRef]

18. Chilla B, Hauser N, Singer G, Trippel M, Froehlich JM, Kubik- Huch RA. Indeterminate adnexal masses at ultrasound: effect of MRI imaging findings on diagnostic thinking and therapeutic decisions. Eur Radiol. 2011;21(6):1301–10. [CrossRef]

19. Iglesias DA, Ramirez PT. Role of minimally invasive surgery in staging of ovarian cancer. Curr Treat Options Oncol. 2011 Sep;12(3):217-29. [CrossRef]

20. Schorge JO, Eisenhauer EE, Chi DS. Current surgical management of ovarian cancer. Hematol Oncol Clin North Am. 2012 Feb;26(1):93-109. [CrossRef]

21. Morice P, Camatte S, Larregain-Fournier D, Thoury A, Duvillard P, Castaigne D. Port-site implantation after laparoscopic treatment of borderlineovarian tumours. Obstet Gynecol. 2004;104(5 Pt 2):1167-70. [CrossRef]

22. Timmerman D, Testa AC, Bourne T, Ameye L, Jurkovic D, Van Holsbeke C, et al. Simple ultrasound-based rules for the diagnosis of ovarian cancer. Ultrasound Obstet Gynecol. 2008;31:681-90. [CrossRef]

23. Timmerman D, Van Calster B, Testa A, Savelli L, Fischerova D, Froyman W, et al. Predicting the risk of malignancy in adnexal masses based on the simple rules from the international ovarian tumour analysis group. Am J Obstet Gynecol. 2016;214:424–37

Kaynak Göster

Bibtex @araştırma makalesi { iuitfd931644, journal = {Journal of Istanbul Faculty of Medicine}, issn = {}, eissn = {1305-6441}, address = {}, publisher = {İstanbul Üniversitesi}, year = {2021}, volume = {84}, pages = {192 - 196}, doi = {10.26650/IUITFD.2020.0038}, title = {CLINICOPATHOLOGIC FEATURES OF PROBABLY MALIGNANT ADNEXAL MASSES WITHOUT SIGNS OF ASCITES AND CARCINOMATOSIS}, key = {cite}, author = {Yumru Çeliksoy, Harika and Sözen, Hamdullah and Baktıroğlu, Hatice Merve and Topuz, Samet and Salihoğlu, Yavuz} }
APA Yumru Çeliksoy, H , Sözen, H , Baktıroğlu, H , Topuz, S , Salihoğlu, Y . (2021). CLINICOPATHOLOGIC FEATURES OF PROBABLY MALIGNANT ADNEXAL MASSES WITHOUT SIGNS OF ASCITES AND CARCINOMATOSIS . Journal of Istanbul Faculty of Medicine , 84 (2) , 192-196 . DOI: 10.26650/IUITFD.2020.0038
MLA Yumru Çeliksoy, H , Sözen, H , Baktıroğlu, H , Topuz, S , Salihoğlu, Y . "CLINICOPATHOLOGIC FEATURES OF PROBABLY MALIGNANT ADNEXAL MASSES WITHOUT SIGNS OF ASCITES AND CARCINOMATOSIS" . Journal of Istanbul Faculty of Medicine 84 (2021 ): 192-196 <https://dergipark.org.tr/tr/pub/iuitfd/issue/62206/931644>
Chicago Yumru Çeliksoy, H , Sözen, H , Baktıroğlu, H , Topuz, S , Salihoğlu, Y . "CLINICOPATHOLOGIC FEATURES OF PROBABLY MALIGNANT ADNEXAL MASSES WITHOUT SIGNS OF ASCITES AND CARCINOMATOSIS". Journal of Istanbul Faculty of Medicine 84 (2021 ): 192-196
RIS TY - JOUR T1 - CLINICOPATHOLOGIC FEATURES OF PROBABLY MALIGNANT ADNEXAL MASSES WITHOUT SIGNS OF ASCITES AND CARCINOMATOSIS AU - Harika Yumru Çeliksoy , Hamdullah Sözen , Hatice Merve Baktıroğlu , Samet Topuz , Yavuz Salihoğlu Y1 - 2021 PY - 2021 N1 - doi: 10.26650/IUITFD.2020.0038 DO - 10.26650/IUITFD.2020.0038 T2 - Journal of Istanbul Faculty of Medicine JF - Journal JO - JOR SP - 192 EP - 196 VL - 84 IS - 2 SN - -1305-6441 M3 - doi: 10.26650/IUITFD.2020.0038 UR - https://doi.org/10.26650/IUITFD.2020.0038 Y2 - 2021 ER -
EndNote %0 İstanbul Tıp Fakültesi Dergisi CLINICOPATHOLOGIC FEATURES OF PROBABLY MALIGNANT ADNEXAL MASSES WITHOUT SIGNS OF ASCITES AND CARCINOMATOSIS %A Harika Yumru Çeliksoy , Hamdullah Sözen , Hatice Merve Baktıroğlu , Samet Topuz , Yavuz Salihoğlu %T CLINICOPATHOLOGIC FEATURES OF PROBABLY MALIGNANT ADNEXAL MASSES WITHOUT SIGNS OF ASCITES AND CARCINOMATOSIS %D 2021 %J Journal of Istanbul Faculty of Medicine %P -1305-6441 %V 84 %N 2 %R doi: 10.26650/IUITFD.2020.0038 %U 10.26650/IUITFD.2020.0038
ISNAD Yumru Çeliksoy, Harika , Sözen, Hamdullah , Baktıroğlu, Hatice Merve , Topuz, Samet , Salihoğlu, Yavuz . "CLINICOPATHOLOGIC FEATURES OF PROBABLY MALIGNANT ADNEXAL MASSES WITHOUT SIGNS OF ASCITES AND CARCINOMATOSIS". Journal of Istanbul Faculty of Medicine 84 / 2 (Nisan 2021): 192-196 . https://doi.org/10.26650/IUITFD.2020.0038
AMA Yumru Çeliksoy H , Sözen H , Baktıroğlu H , Topuz S , Salihoğlu Y . CLINICOPATHOLOGIC FEATURES OF PROBABLY MALIGNANT ADNEXAL MASSES WITHOUT SIGNS OF ASCITES AND CARCINOMATOSIS. İst Tıp Fak Derg. 2021; 84(2): 192-196.
Vancouver Yumru Çeliksoy H , Sözen H , Baktıroğlu H , Topuz S , Salihoğlu Y . CLINICOPATHOLOGIC FEATURES OF PROBABLY MALIGNANT ADNEXAL MASSES WITHOUT SIGNS OF ASCITES AND CARCINOMATOSIS. Journal of Istanbul Faculty of Medicine. 2021; 84(2): 192-196.
IEEE H. Yumru Çeliksoy , H. Sözen , H. Baktıroğlu , S. Topuz ve Y. Salihoğlu , "CLINICOPATHOLOGIC FEATURES OF PROBABLY MALIGNANT ADNEXAL MASSES WITHOUT SIGNS OF ASCITES AND CARCINOMATOSIS", Journal of Istanbul Faculty of Medicine, c. 84, sayı. 2, ss. 192-196, Nis. 2021, doi:10.26650/IUITFD.2020.0038

28816 16029

Arşiv
Sayıdaki Diğer Makaleler

IN VIVO MODELDE YARIK DAMAK CERRAHİSİNDE N-BUTİL-2-SİYANOAKRİLATIN KULLANIMI VE ETKİNLİĞİNİN SÜTÜR MATERYALİ İLE KARŞILAŞTIRILMASI

Furkan KARABULUT, Serhat ÖZBEK

DEPRESYON VE KİŞİLİK DEĞİŞİKLİLERİ İLE ORTAYA ÇIKAN GLİOBLASTOMA: BİR OLGU SUNUMU

Yaşar KAPICI, Olga BAYAR KAPICI, Aslı EGELİ, Atilla TEKİN

OKUL YAŞINDAKİ ÇOCUKLARIN BESLENME VE ÜRİNER İYOT DÜZEYLERİ ARASINDA BİR İLİŞKİ VAR MI?

Yetunde T OLASINDE, Omatayo O ADESİYUN, Rasaq R OLAOSEBIKAN, Adeola OLASİNDE, Olayinka R IBRAHİM, Samuel K ERNEST

VARİS KANAMASI OLAN SİROZ HASTALARINDA QTC İNTERVALİNİN DEĞERLENDİRİLMESİ

Rezan KARAALİ, Umut PAYZA, Ahmet KAYALI, Firdevs TOPAL, Fatih Esad TOPAL

VULVAR HİDRADENOMA PAPİLLİFERUM: OLGU SUNUMU

Ayhan ATIGAN, Derya KILIÇ, Yeliz ARMAN KARAKAYA, Ömer Tolga GÜLER

YÜZEYEL EEG’DE FARKLI İKTAL YAYILIM PATERNLERİ GÖSTEREN İLACA DİRENÇLİ TEMPORAL LOB EPİLEPSİLİ HASTALARDA POZİTRON EMİSYON TOMOGRAFİ

Nermin Görkem ŞİRİN, Bedia MARANGOZOĞLU, Ebru YILMAZ, Ayşen GÖKYİĞİT, Betül BAYKAN, Candan GÜRSES, Nerses BEBEK

HOLOPROZENSEFALİ: 127 ANTENATAL OLGUNUN ETYOPATOGENEZİNDE KROMOZOM ANOMALİLERİ

Birsen KARAMAN, Selvi ERGİN, Hülya KAYSERİLİ, Atıl YÜKSEL, Nihan Bilge SATKIN, İbrahim Halil KALELİOĞLU, Recep HAS, Seher BAŞARAN

HEMATOLOJİK KANSER TANISI ALAN BİREYLERDE DİSTRES VE ALEKSİTİMİNİN İNCELENMESİ

Didem AYHAN, Neşe MERCAN, Reyhan DOĞAN, Çiğdem YÜKSEK

ERKEN VE GEÇ BAŞLANGIÇLI ALZHEIMER HASTALARININ PERİFERİK KANLARINDA SEÇİLMİŞ miRNA’LARIN ANLATIM DÜZEYİ

Gamze GÜVEN, Ebba LOHMANN, Çağrı GÜLEÇ, Başar BİLGİÇ, Ebru ÖZER, Haşmet HANAĞASI, Hakan GÜRVİT, Nihan ÜNALTUNA

EGZERSİZ VE NÖROGENEZ

Mehmet ÜNAL